Search Results
Jun 04, 2026, 06:00 ET DXC förenklar och stärker If's teknikmiljö i Norden med DXC OASIS
och lösningar till globala företag och offentliga organisationer — och hjälper dem att utnyttja AI för att skapa resultat med hög hastighet i en tid av exponentiell förändring. Med djup expertis inom Managed Infrastructure Services, Application Modernization och branschspecifika mjukvarulösningar moderniserar,
More news about: DXC Technology Company
Jun 04, 2026, 04:35 ET World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA
81-87.Chan WL, Lam KO, So TH, et al. Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review. Ther Adv Med Oncol. 2019;11:1758835919859990.
More news about: Innovent Biologics
Jun 04, 2026, 03:00 ET UGREEN går med i 2026 Terra Wortmann Open som officiell partner med "Kraft för ditt spel"
Retractable Series full beredskap med inbyggda utdragbara kablar och kraftfull samtidig laddning av flera enheter. För personal eller medieteam som hanterar flera enheter erbjuder serien en allt-i-ett-lösning med inbyggda kablar, utgång med hög kapacitet och laddning med flera enheter, vilket säkerställer
More news about: UGREEN Limited
Jun 04, 2026, 03:00 ET UGREEN bliver officiel partner for Terra Wortmann Open 2026 med sloganet "Strøm til dit spil"
der har brug for strøm med større kapacitet, sikrer Nexode Retractable-serien fuld beredskab med indbyggede udtrækkelige kabler og kraftfuld opladning af flere enheder. For medarbejdere eller medieteams, der administrerer flere enheder, tilbyder serien en alt-i-én-løsning med indbyggede kabler, høj udgangseffekt
More news about: UGREEN Limited
Jun 04, 2026, 03:00 ET UGREEN blir med i 2026 Terra Wortmann Open som offisiell partner med "Power for Your Game»
høyere kapasitetskraft, sikrer Nexode Retractable Series full beredskap med innebygde tilbaketrekkbare kabler og kraftig multi-enhet lading. For ansatte eller medieteam som administrerer flere enheter, gir serien en alt-i-ett-løsning, med innebygde kabler, høykapasitetsutgang og multi-enhet lading, slik at
More news about: UGREEN Limited
Jun 03, 2026, 15:33 ET EUROPÄISCHE KOMMISSION ERTEILT ZULASSUNG FÜR IMDYLLTRA® VON AMGEN FÜR DIE BEHANDLUNG VON KLEINZELLIGEM LUNGENKREBS IM FORTGESCHRITTENEN STADIUM
(Investoren) REFERENZENMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg und 10 mg Pulver für Konzentrat und Infusionslösung: Zusammenfassung der Produkteigenschaften.
More news about: Amgen
Jun 03, 2026, 15:16 ET LA COMMISSION EUROPÉENNE APPROUVE IMDYLLTRA® D'AMGEN POUR LE TRAITEMENT DU CANCER DU POUMON À PETITES CELLULES DE STADE ÉTENDU
(investisseurs) RÉFÉRENCESMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Résumé des caractéristiques du
More news about: Amgen
Jun 03, 2026, 14:25 ET EURÓPSKA KOMISIA SCHVÁLILA LIEK IMDYLLTRA® SPOLOČNOSTI AMGEN NA LIEČBU POKROČILÉHO ŠTÁDIA MALOBUNKOVÉHO KARCINÓMU PĽÚC
(investori) REFERENCIEMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4): 349 – 361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product characteristics.
More news about: Amgen
Jun 03, 2026, 13:35 ET EVROPSKÁ KOMISE SCHVÁLILA PŘÍPRAVEK IMDYLLTRA® OD SPOLEČNOSTI AMGEN K LÉČBĚ EXTENZIVNÍHO STADIA MALOBUNĚČNÉHO KARCINOMU PLIC
(investoři) OdkazyMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product
More news about: Amgen
Jun 03, 2026, 10:21 ET KOMISJA EUROPEJSA ZATWIERDZA PREPARAT IMDYLLTRA® FIRMY AMGEN DO LECZENIA DROBNOKOMÓRKOWEGO RAKA PŁUCA W POSTACI ROZSIANEJ
cancer after platinum-based chemotherapy (Tarlatamab w drobnokomórkowym raku płuca po chemioterapii opartej na związkach platyny). N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product
More news about: Amgen
Jun 03, 2026, 09:43 ET ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
ЛИТЕРАТУРЫMountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 мг и 10 мг порошок для концентрата и раствор для инфузий: Summary of product characteristics.
More news about: Amgen
Jun 03, 2026, 09:27 ET LA CE APRUEBA IMDYLLTRA® DE AMGEN PARA EL CÁNCER DE PULMÓN DE CÉLULAS PEQUEÑAS EN ESTADIO AVANZADO
Mountzios G, Sun L, Cho BC, et al. Tarlatamab in small-cell lung cancer after platinum-based chemotherapy. N Engl J Med. 2025;393(4):349-361.Amgen. (2026) Imdylltra 1 mg and 10 mg powder for concentrate and solution for infusion: Summary of product
More news about: Amgen
Jun 03, 2026, 09:00 ET AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
Associations for Rheumatology (EULAR) 2026 Congress. June 3-6, 2026: Abstract #POS0867.Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-551.Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol.
More news about: Amgen
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-96. PMID 16625125. Specification Data on File, Becton, Dickinson and Company 2026. Specification data from BACT/ALERT®
More news about: Waters Corporation
Jun 03, 2026, 08:00 ET Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589-96. PMID 16625125. Specification Data on File, Becton, Dickinson and Company 2026. Specification data from BACT/ALERT®
More news about: Waters Corporation
Jun 03, 2026, 07:47 ET A World First: A Major Innovation in Blood Transfusion
investment.1 Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326CAUTION:The FrontlineODP™ Spray Dried Plasma System has not received FDA or EU approval for any indication.
More news about: Velico Medical, Inc
Jun 03, 2026, 07:41 ET A World First: A Major Innovation in Blood Transfusion
investment.1 Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326CAUTION:The FrontlineODP™ Spray Dried Plasma System has not received FDA or EU approval for any indication.
More news about: Velico Medical, Inc
Jun 03, 2026, 06:45 ET Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years
understanding the company's underlying operational performance and trends and to facilitate comparisons with the performance of other companies in the med tech industry. Non-GAAP net income and diluted EPS exclude the effect of certain charges or gains that contribute to or reduce earnings but that result
More news about: Medtronic plc
Jun 03, 2026, 00:04 ET Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
2026.8 Kawka L, et al. Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management. J Clin Med. 2021 Sep 3;10(17):3996. doi: 10.3390/jcm10173996. PMID: 34501444; PMCID: PMC8432566.9 Guéry JC. Why Is Systemic Lupus Erythematosus
More news about: Johnson & Johnson
Jun 03, 2026, 00:03 ET Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease
10.1038/s41584-023-01057-6.7 Meudec L, Nocturne G, Mariette X. Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction. J Clin Med. 2026 Mar 4;15(5):1945. doi: 10.3390/jcm150519458 Mayo Clinic. Sjogren's syndrome. Available at:
More news about: Johnson & Johnson
Jun 02, 2026, 20:24 ET Hydreight Announces Refiling of Interim Financial Statements
directly to patients at home, office or hotel. Hydreight is bridging the gap between provider compliance and patient convenience, empowering nurses, med spa technicians and other licensed healthcare professionals. The Hydreight platform allows healthcare professionals to deliver services independently,
More news about: Hydreight Technologies Inc.
Jun 02, 2026, 14:18 ET The Inner Circle acknowledges Ashley "Ash" Spoto, M.Ed as a Pinnacle Professional of The Year
multimedia:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-ashley-ash-spoto-med-as-a-pinnacle-professional-of-the-year-302788897.htmlSOURCE
More news about: The Inner Circle
Jun 02, 2026, 13:00 ET Alani Skin MD Named "Best Med Spa" in 2026 Best of the Desert Community's Choice Awards
SCOTTSDALE, Ariz., June 2, 2026 /PRNewswire/ -- Alani Skin MD has been named "Best Med Spa" in the 2026 Best of the Desert Community's Choice Awards, a voter-driven program recognizing standout businesses and service providers across Arizona.
More news about: Alani Skin MD
Jun 02, 2026, 11:00 ET Fingerpaint Group Names Sarah Cherng as Chief Technology & Product Officer Role
GroupFingerpaint Group is an award-winning, top 20 healthcare agency and a unified commercialization platform for the life sciences, named Med Ad News Network of the Year in 2026. Partnering with 95% of the top 20 global pharmaceutical companies, Fingerpaint Group combines imagination with innovation
More news about: Fingerpaint Group
Jun 02, 2026, 08:38 ET Predictive Ballistics Selected as Primary Supplier of Overt Armor Kit (OAK) by Federal Bureau of Investigation (FBI)
offers a number of recognized brand names in these markets including Safariland® Armor, Duty Gear and Communications, Bianchi®, Break Free®, Hatch®, Med-Eng®, Identicator® and NIK®. The Safariland Group's mission, "Together, We Save Lives®," is inherent in the lifesaving and protective products it delivers.
More news about: Predictive Ballistics